Laboratory Benchtop Automation Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview

The Laboratory Benchtop Automation Market is expected to grow from USD 1,325 million in 2024 to approximately USD 2,033.45 million by 2032, at a compound annual growth rate (CAGR) of 5.5% over the forecast period.

This growth is driven by the rising demand for high-throughput testing in diagnostic laboratories and research settings, alongside an increasing focus on personalized medicine and accelerated drug discovery. Integration of artificial intelligence (AI) and machine learning (ML) into benchtop automation enhances data accuracy, streamlines complex processes, and improves overall laboratory efficiency.

Advancements in miniaturization and modular system designs are making automation more accessible to small and mid-sized labs, expanding the market’s reach. Additionally, stringent regulatory standards in pharmaceutical and clinical testing are reinforcing the need for consistent and precise automated workflows, positioning benchtop automation as an essential tool for compliance and quality assurance.
Market Drivers
1. Rise of Personalized Medicine and Drug Discovery

The increasing global focus on personalized treatment approaches and rapid drug development pipelines is fueling demand for benchtop automation systems. These technologies support high-throughput screening, large-scale data processing, and precise workflow management, which are critical in genomics, proteomics, and metabolomics research.

For example, systems like Illumina’s NextSeq 2000 enable sequencing at a scale that supports personalized healthcare by delivering up to 1,200 gigabases per run. Automation in such settings enables laboratories to reduce turnaround time, increase accuracy, and manage costs more effectively—making it an indispensable asset in modern biomedical research and pharmaceutical R&D.
Market Challenges
1. High Capital Investment and Maintenance Costs

One of the major barriers to widespread adoption of laboratory benchtop automation is the high upfront cost of equipment procurement, integration, and ongoing maintenance. Smaller laboratories often struggle with the financial burden of acquiring advanced systems, especially when combined with the need for technical training, software integration, and routine system upkeep.

In emerging markets or resource-limited settings, these costs can be particularly prohibitive, limiting access to automation technologies despite the clear operational benefits. The requirement for skilled technicians to operate and troubleshoot equipment further adds to the total cost of ownership, impacting adoption rates.
Market Segmentation
By Product Type

Automated Liquid Handling & Dispensing Systems

Sample Storage and Handling Equipment

Robotic Systems

System Accessories

By End Use

Research & Development Institutes

Pharmaceutical Companies

Hospitals & Diagnostic Centers

Other End Users

By Region

North America: U.S., Canada, Mexico

Europe: Germany, France, U.K., Italy, Spain, Rest of Europe

Asia Pacific: China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific

Latin America: Brazil, Argentina, Rest of Latin America

Middle East & Africa: GCC Countries, South Africa, Rest of MEA

Key Market Players

Abbott

Agilent Technologies

Beckman Coulter Inc.

BioTek Instruments

Danaher Corporation

Eppendorf

Logos Biosystems Inc.

PerkinElmer

QIAGEN

Siemens Healthcare

Thermo Fisher Scientific